Skip to content

A Clinical trial to evaluate the efficacy of Hingu churna in the management of kashtartava w.s.r. to primary dysmenorrhea.

RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF HINGU CHURNA IN THE MANAGEMENT OF KASHTARTAVA W.S.R. TO PRIMARY DYSMENORRHOEA - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088800
Enrollment
80
Registered
2025-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr. Rutuja Subhash Dhanawade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age group of 13 to 25 years. 2. Patient having symptoms of kashtartava w.s.r to primary dysmennorhoea i.e. a) Sakasht Rajastrav(Painful Menstruation) b) Alpa Rajastrav (Scanty Menstruation) c) Adhoudara Shool (Pain in lower abdomen) d) Katishool (Pain in pelvic region) 3. Associated symptoms a )Prasek (nausea ) b) Chardi (vomiting) c) Atisara(diarrhea) d)Shirashool(headache)

Exclusion criteria

Exclusion criteria: 1 Patient age below 13 years and above 25 years. 2 Patient having k/c/o Congenital anomalies leading to [Page : 12] kashtartava w.s.r to primary dysmenorrhea. 3 Patient having k/c/o Acute infection, acyclic and excessive bleeding more than 4 pads / days or more 5 days. 4 Patient having k/c/o Endometriosis, Adenomyosis, Uterine fibroid, Endometrial polyp and Other medical, surgical etc. 5 Patients with any k/c/o systemic disorders like DM, HTN etc.

Design outcomes

Primary

MeasureTime frame
Randomized controlled clinical trial to evaluate the efficacy of hingu churna in the management of kashtartava with special reference to primary dysmenorrheaTimepoint: 60 days

Secondary

MeasureTime frame
usg abdomen and pelvis will be done to rule ought uterine pathology.Timepoint: before treatment and after treatment

Countries

India

Contacts

Public ContactDr Sonal Wagh

Sangam Sevabhavi Trust Ayurved Medical Collage Sangamner.

rutujadhanawade1998@gmail.com9860355355

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026